Tagged biotech
Press Release
Hyris Fulfils Its Integration Into Ulisse Biomed to Give Birth to a New International Group Ready to Make Its Mark in the Global Biotech Market
Following the first official announcement at the beginning of December last year, Hyris completed the transfer of its shares into Ulisse Biomed via a reverse take-over transaction. The new group, strong of flawless interoperability between its leading technologies, aims to become a new benchmark of innovation in the national and international biotech market. Read More
Press Release
Hyris Supports Researchers and Developers to Launch Testing Kits via New Onboarding Programs
Following the launch of its Marketplace in 2022, Hyris continues to leverage the AI capabilities of its genetic testing platform, renowned for its adaptability, to support both researchers and kit developers worldwide. New onboarding programs enable emerging players to accelerate their go-to-market, as well as established manufacturers and diagnostic providers to integrate their portfolio with ease, maximizing their cost-per-value strategy. Read More
Press Release
AnaBios Boosts Discovery of Safer, More Effective Medicines With License From the University of Louisville
The agreement will drive the discovery of more effective treatments for cardiovascular disease and development of safer drugs with the preclinical implementation of advanced human heart models Read More
Press Release
Envision Pharma Group Acquires OKRA.ai
Pivotal acquisition in Envision Pharma Group's tech-enabled offerings provides clients with access to advanced AI to accelerate decision-making that optimizes their products' path to market and ultimately supports the delivery of enhanced patient outcomes. Read More
Press Release
Neurocentria Announces Dr. Thomas Südhof to Join the Scientific Advisory Board
The appointment further strengthens the company's scientific resources, including in neuronal function and synaptic transmission, which are central to Neurocentria's approach for developing novel therapies for neurodegenerative and neuropsychiatric disorders. Read More
Press Release
TRESTLE Compliance and qordata Announce Consulting/Technology Partnership
Expert life science compliance consulting firm TRESTLE Compliance partners with qordata to leverage TRESTLE's compliance expertise and qordata's compliance management tools to provide life science innovators comprehensive compliance solutions that mitigate risks and maximize effectiveness. Read More
Press Release
Panoramic Health Launches Clinical Research Division to Drive Discovery of Novel Kidney Disease Therapies
Clinical Research Division to Offer Full-Service Support, Removing Barriers to Kidney Care Innovation by Providing Access to Large Patient Populations, Trial-Ready Sites, Principal Investigators Read More
Press Release
Giving 23 a Whole New Meaning: Social Responsibility and P23
P23 gives back regularly throughout the year, starting in January, with efforts ranging from monetary donations to back-to-school drives as a symbol to its social responsibility centered around the 23rd of each month and ending with the 23 Days of Giving in December Read More
Press Release
Hyris' New T-Cell Test is Finally Available to EU Countries to Easily Map Patients' Cellular Immunity to SARS-CoV-2
After months of experimentation in partnership with some world-class schools of medicine and top-tier diagnostic providers, the much-anticipated T-Cell Test from Hyris, based on innovative qPCR technology, is finally available for the European market with a CE-IVD mark. The new Test will change the way laboratories and diagnostic providers track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of the Hyris System™. Read More
Press Release
A New T-Cell activation assay based on Hyris qPCR Technology marks a disruptive approach for the detection of SARS-CoV-2 specific cellular immunity
A scientific paper recently published in Nature Biotechnology reveals new research regarding how we track and monitor T-cell patients' immunity to SARS-CoV-2, leveraging the unique characteristics of Hyris System™. The study results from a joint effort of an international research team from the Icahn School of Medicine at Mount Sinai, Singapore Duke-NUS Medical School, laboratory diagnostic service providers Synlab, and Hyris. Read More
Press Release
KoreSummit Helps Companies and Entrepreneurs in the Health Industry Raise Capital Compliantly
Medtech, Biotech, and Pharma industries will gather for the Medtech A+ Team - how to do a successful RegA+ for a Medtech company in a different format, with quicker panels and more information Read More
Press Release
Recardio and FDA Reach Agreement on Pivotal Phase 3 Trial Design
Recardio Inc., a late stage clinical-stage life science company developing regenerative therapies for cardiovascular diseases, announced that the FDA concurs with Recardio's pivotal Heal-MI Phase 3 trial design with Dutogliptin in Acute Myocardial Infarction. Read More
Press Release
Recardio's Positive Phase 2 Results Presented as Latebreaker at World Congress on Acute Heart Failure 2022 in Madrid
Recardio Inc., a clinical-stage life science company developing regenerative therapies for cardiovascular diseases, announced that the positive study results of Recardio's Phase 2 clinical study in Acute Myocardial Infarction were presented on Saturday, May 21, 2022, during the Latebreaker Session at the World Congress on Acute Heart Failure 2022 in Madrid. Read More
Press Release